This is a Validated Antibody Database (VAD) review about human UBE2F, based on 2 published articles (read how Labome selects the articles), using UBE2F antibody in all methods. It is aimed to help Labome visitors find the most suited UBE2F antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
UBE2F synonym: NCE2

Knockout validation
Abcam
domestic rabbit monoclonal (EPR12932)
  • western blot knockout validation; human; loading ...; fig 3s1b
Abcam UBE2F antibody (Abcam, ab185234) was used in western blot knockout validation on human samples (fig 3s1b). elife (2019) ncbi
Abcam
domestic rabbit monoclonal (EPR12932)
  • western blot knockout validation; human; loading ...; fig 3s1b
Abcam UBE2F antibody (Abcam, ab185234) was used in western blot knockout validation on human samples (fig 3s1b). elife (2019) ncbi
domestic rabbit monoclonal (EPR12932)
  • western blot; human; loading ...; fig 4b
Abcam UBE2F antibody (Abcam, Ab185234) was used in western blot on human samples (fig 4b). Cancer Chemother Pharmacol (2018) ncbi
Articles Reviewed
  1. Kabir S, Cidado J, Andersen C, Dick C, Lin P, Mitros T, et al. The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells. elife. 2019;8: pubmed publisher
  2. Xu B, Deng Y, Bi R, Guo H, Shu C, Shah N, et al. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification. Cancer Chemother Pharmacol. 2018;81:1083-1093 pubmed publisher